Webinar to Feature Experts Dr. Stephen Collett and Dr. Fernando Vargas
SUMMIT, NEW JERSEY, June 13, 2014 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced an educational webinar to help poultry producers improve the performance of their flocks by creating a more productive intestinal health environment.
“Through the ‘Go Beyond’ program, Merck Animal Health offers poultry producers numerous tools to help them ensure the intestinal health of their flocks and improve productivity,” said Jonathan Perkins, Merck Animal Health. “We are pleased to offer this webinar to educate producers about why a balanced and stable gut is essential for poultry health and performance.”
The webinar will provide poultry producers the opportunity to learn how to utilize the basic principles of gut flora development, manage the lower intestine beyond digestion, and rehabilitate intestinal microflora. Participants will also learn about tools for reducing harmful microflora that can impair performance.
The webinar will feature presentations from industry experts, including Dr. Stephen Collett, clinical associate professor at the Poultry Diagnostic and Research Center (PDRC) in the College of Veterinary Medicine at The University of Georgia, and Dr. Fernando Vargas, global technical director, Merck Animal Health.
The webinar, “Optimizing the Gut Environment for Improved Performance,” will be held on Thursday, June 19 at 8:30 a.m. CDT. Poultry producers can register for the webinar for free by clicking here.
About Merck Animal Health
Today’s Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck (NYSE: MRK). Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com or connect with us on Twitter at @MerckAH.
Merck forward-Looking Statement
This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2013 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).